Journals / Türk Girişimsel Kardiyoloji Derg. / 2009 / Cilt: 13 - Sayı: 2

Approach to patients with postoperative atrial fibrillation

Pages
66–75
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here we reviewed current management modalities for POAF.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Atrial fibrillation (AF) is one of the most frequent arrhythmias following cardiothoracic surgery and, can cause hemodynamic instability, prolonged hospital stay and increased costs, and predisposes to cerebrovascular incidents.
📊
Key Findings & Data:The current therapeutic strategies in the management of POAF include prophylactic use of pharmacologic agents in the perioperative period to prevent the occurrence of AF and use of rate-controlling medications to control ventricular response, and if spontaneous conversion does not occur, use of pharmacologic or electrical cardioversion with or without concomitant anticoagulant therapy.
💡
Conclusion & Impact:Here we reviewed current management modalities for POAF.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Atrial fibrillation (AF) is one of the most frequent arrhythmias following cardiothoracic surgery and, can cause hemodynamic instability, prolonged hospital stay and increased costs, and predisposes to cerebrovascular incidents. There is no consensus regarding management of postoperative AF (POAF). The current therapeutic strategies in the management of POAF include prophylactic use of pharmacologic agents in the perioperative period to prevent the occurrence of AF and use of rate-controlling medications to control ventricular response, and if spontaneous conversion does not occur, use of pharmacologic or electrical cardioversion with or without concomitant anticoagulant therapy. Here we reviewed current management modalities for POAF.

Özet

Atriyal fibrillasyon (AF) kardiyotorasik cerrahi sonrası en sık görülen aritmilerden olup hemodinamik bozulmaya, hastanede yatış süresinin uzamasına ve hastane giderlerinin artmasına yol açabilir ve serebrovasküler olaylara zemin hazırlar. Postoperatif AF'na (POAF) yaklaşım konusunda fikir birliği bulunmamaktadır. POAF'a yönelik yaklaşımlar perioperatif dönemde AF oluşmasını önleyici ve ventrikül hızını kontrol edici ilaçları ve spontan konversiyonun gerçekleşmemesi durumunda antikoagülan tedavinin eşlik ettiği veya etmediği farmakolojik ya da elektriki kardiyoversiyonu içerir. Biz bu yazıda POAF'a güncel yaklaşım metodlarını gözden geçirdik.

🔖

Cite This Article

GÜNEŞ, Y., DOĞAN, S. M., TUNCER, M. (2022). Approach to patients with postoperative atrial fibrillation. Türk Girişimsel Kardiyoloji Derg., Cilt: 13 - Sayı: 2, 66–75. https://ajindex.com/articles/624475

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Banach M, Misztal M, Goch JH, et al. Predictors of atrial fibrillation in patients following isolated surgical revascularization. A metaanalysis of 9 studies with 28786 patients. Arch Med Sci 2007; 3: 229-39
  2. Funk M, Richards SB, Desjardins J, Bebon C. Incidince, timing, symptoms, and risk factors for atrial fibrillation after cardiac surgery. Am J Crit Care 2003; 12:424-35
  3. Dogan SM, Buyukates M, Kandemir O, et al. Pre- dictors of atrial fibrillation after coronary artery bypass surgery. Coron Artery Dis. 2007;18:327- 31
  4. Vaporciyan AA, Correa AM, Rice DC, et al. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg. 2004; 127:779-86
  5. Mathew JP, Fontes ML, Tudor IC, et al; Investi- gators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004;291:1720-29
  6. Gillespie El, White CM, Kluger J, Rancourt JA, Gallagher R, Coleman CI. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery. Pharmacotherapy 2006; 26:499-504
  7. Myers MG, Alnemri K. Rate control therapy for atrial fibrillation following coronary artery bypass surgery. Can J Cardiol 1998;14: 363-66
  8. Tisdale JE, Padhi ID, Goldberg AD, et al. A ran- domized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery. Am Heart J 1998; 35:739-47
  9. Lahey SJ, Campos CT, Jennings B, et al. Hospi- tal readmission after cardiac surgery: does "fast track" cardiac surgery result in cost saving or cost shifting? Circulation 1998; 98 (Suppl II): 35-40
  10. Crystal E, Garfinkle MS, Connolly SS, et al. Inter- ventions for preventing post-operative atrial fibril- lation in patients undergoing heart surgery. Cochrane Database Syst Rev 2004;CD003611
  11. Fuster V, Ryden LE, Crijns HJ, et al: ACC/ AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Commit- tee for Practice Guidelines and Policy Confer- ences (Writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Soc